News and Trends 4 Nov 2024Top biotech deals of October 2024 Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024. November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2024Booster launches to treat neurodegenerative diseases with proteasome activation Discover Booster Therapeutics’ novel proteasome activation approach to neurodegenerative diseases as it launches with $15 million. October 15, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 10 May 2024Cytokinetics’ cardiovascular pipeline beats strong Discover Cytokinetics’ groundbreaking cardiovascular treatments, including heart drug aficamten, in our latest podcast with CEO Robert Blum. May 10, 2024 Share WhatsApp Twitter Linkedin Email
In Depth 9 May 2024BTK inhibitors: can these drugs tackle cancer and autoimmunity? BTK inhibitors were first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases. May 9, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 17 Apr 2024Small but mighty: The role of small-molecule drugs in disease treatment Find out more about small-molecule drugs, including how they work and what their advantages and disadvantages are. April 17, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 27 Mar 2024Are new treatments for multiple sclerosis on the horizon? As the wait for new multiple sclerosis treatments continue, here are some ongoing clinical trials that hold promise. March 27, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 25 Mar 2024Beyond Wegovy: Could Novo Nordisk’s new experimental weight loss pill be even better? Discover how Novo Nordisk’s new experimental obesity pill, amycretin, could be even more efficient for weight loss than Wegovy. March 25, 2024 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 20 Mar 2024Are molecular glues the key to undruggable targets? As more biopharmas get sticky with molecular glue developers and venture capital interest grows, here is a review of the field. March 20, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Mar 20246 biotech companies tackling antibiotic resistance Discover six antibiotic companies developing novel therapies in an attempt to overcome the global issue of antibiotic resistance. March 7, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 4 Mar 2024ALS: how close are we to a cure? Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years. March 4, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Feb 20246 biotech companies making a difference in pediatric care Take a closer look at six pediatric companies taking innovative approaches to tackle illnesses affecting children. February 29, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 15 Feb 2024Turning the tide: recent advancements in childhood cancer research As we observe International Childhood Cancer Day today, let us take a look at some of the recent advancements in childhood cancer research. February 15, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email